![](https://endpts.com/wp-content/uploads/2022/06/Rob-Davis-Merck-tile1.jpg)
Rob Davis, Merck CEO
Updated: Merck looking at Seagen takeover bid in the wake of Clay Siegall's resignation — report
Merck is evaluating a potential buyout of embattled Seattle biotech Seagen, according to a report from the Wall Street Journal on …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.